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Nitric oxide (NO) is a diffusible regulatory molecule involved in a wide range of physio-
logical and pathological events. At the tissue level, a local and temporary increase in NO
concentration is translated into a cellular signal. From our current knowledge of biological
synthesis and decay, the kinetics and mechanisms that determine NO concentration dynamics
in tissues are poorly understood. Generally, NO mediates its effects by stimulating (e.g.,
guanylate cyclase) or inhibiting (e.g., cytochrome oxidase) transition metal-containing pro-
teins and by post-translational modification of proteins (e.g., formation of nitrosothiol ad-
ducts). The borderline between the physiological and pathological activities of NO is a matter
of controversy, but tissue redox environment, supramolecular organization and compart-
mentalisation of NO targets are important features in determining NO actions. In brain, NO
synthesis in the dependency of glutamate NMDA receptor is a paradigmatic example; the
NMDA-subtype glutamate receptor triggers intracellular signalling pathways that govern
neuronal plasticity, development, senescence and disease, suggesting a role for NO in these
processes. Measurements of NO in the different subregions of hippocampus, in a glutamate
NMDA receptor-dependent fashion, by means of electrochemical selective microsensors
illustrate the concentration dynamics of NO in the sub-regions of this brain area. The analysis
of NO concentration–time profiles in the hippocampus requires consideration of at least two
interrelated issues, also addressed in this review. NO diffusion in a biological medium and
regulation of NO activity.
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Due to its low molecular weight and hydrophobic properties, NO easily perme-
ates cell membranes (Shaw and Vosper, 1977) and may diffuse a few cell diameters
from its site of synthesis to neighbouring cells, providing that the rate of transcellular
diffusion is faster than the rate of its intracellular reactions (Lancaster, 1994; Wood
and Garthwaite, 1994; Beckman and Koppenol, 1996; Lancaster, 1997). Studies
designed to measure the distance of NO diffusion under physiological conditions by
means of electrochemical microsensors reported values of 100–200 lm, rising within
10–15 s to a steady-state concentration, which are consistent with a high diffusion
coefficient, 3300 lm2/s (Malinski et al., 1993; Meulemans, 1994). A first strong
experimental evidence for the intercellular diffusion of NO in the brain came from
the work of Schuman and Madison that were able to show NO-induced synaptic
potentiation between paired neurons and synapses approximately 100 lm distant in
hippocampal slices (Schuman and Madison, 1994). In addition, modelling for NO
diffusion in brain predicted that the physiological sphere of influence of a single
source producing NO for 1–10 s has a diameter of 200 lm, which corresponds to a
volume of brain containing 2 million synapses (Wood and Garthwaite, 1994). These
selected observations support the notion of NO as a diffusible intercellular mes-
senger in the brain. This is clear in the case of long term potentiation (LTP, a leading
experimental model for the synaptic changes that underlie learning and memory) in
hippocampus. The formulation of LTP concept is in connection with NO as an
intercellular messenger because it postulates the existence of a retrograde messenger;
a species that once produced in the post-synaptic terminal was able to reach the
pre-synaptic neuron and cause such an effect. In 1991, two independent groups
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hippocampal CA1 subregion and that NO synthesis was required for LTP to be
observed (O’Dell et al., 1991; Schuman and Madison, 1991). More recently, Arancio
et al. were able to show that NO in cultured hippocampal neurons was produced in
the post-synaptic side of the hippocampal synapse, diffused into the extracellular
space and reached the pre-synaptic terminal, producing LTP (Arancio et al., 1996).
In spite of the NO random spread in all directions driven by a spatial concen-
tration gradient from its original point of synthesis, because NO cannot be neither
stored nor reuptaked into vesicles, the type and number of targets in the vicinity will
determine and shape the NO concentration–time profile. Although NO is not
particularly reactive with the majority of biomolecules, its very fast reactions with
superoxide anion, lipid peroxyl radicals, transition metal-containing proteins, thiols
(in protein residues and low molecular weight compounds, including glutathione and
cysteine) and O2, probably dictate its half-life and regulate its bioavailability. For
instance, in a model system consisting of activated macrophages, NO fluxes were
detected by means of a microelectrode at distances up to 500 lm but the subsequent
addition of proteins and lipids to the medium reduced its diffusional field (Porterfield
et al., 2001). In aqueous solution, NO undergoes a reaction with O2, finally pro-
ducing nitrite, that proceeds slowly at the low O2 concentrations in tissues, but if
considering the hydrophobicity of both NO and O2, it is likely that the reaction of
NO by O2 acquires relevance within the hydrophobic interior of biomembranes (Liu
et al., 1998). Noteworthy, hemoglobin in red blood cells has been suggested to act as
a global ‘‘sink’’, lowering severely the concentration of NO (Lancaster, 1997).
However, selective ‘‘sinks’’ have recently been proposed, including a flavoprotein
active in some cell lines (Gardner et al., 2001) and an unknown protein present in
brain homogenates and independent of several hemeproteins including hemoglobin
and cytochrome oxidase (Griffiths and Garthwaite, 2001). According to this pro-
posal, NO is consumed in the brain by an unknown protein that shapes NO signals.
However, the existence of a specific biological mechanism for inactivating NO has
not been unequivocally identified.
In summary, the diffusional spread of NO in a biological setting will depend not
only on its diffusibility but also on the amount and rate at which it is generated, the
duration of release from a source cell and the rate (and compartmentalisation) of the
NO reactions with O2 and other biological molecules.
From these notions an important question emerged related with NO signalling.
What is the specificity of action of a highly diffusible, reactive and potentially toxic
molecule in a signalling pathway? The answer to this question remains rudimentary.
A first important observation is that the biosynthesis of NO is highly regulated. In
neurons, NO synthesis occurs in a complex sequence of events involving the stim-
ulation of NMDA-subtype glutamate receptors (a voltage-gated ion channel
receptor activated by glutamate) and the influx of Ca2þ to the cytosol that upon
binding to calmodulin activates neuronal nitric oxide synthase (nNOS); the whole
process is achieved in time-scales of a few seconds (Garthwaite and Boulton, 1995).
It is therefore assumed that a critical switch to control nNOS activity, provided that
several cofactors including calmodulin, NADPH, FMN, FAD, tetrahydrobiopterin
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The nNOS activity can be post-translationally regulated by phosphorylation catal-
ysed by multiple kinases, including protein kinase C, cAMP-dependent protein ki-
nase and Ca2þ/calmodulin-dependent protein kinase (Bredt et al., 1992), suggesting
that NO synthesis in response to neuronal stimulation is modulated by multiple
signalling cascades. Additional mechanisms of nNOS regulation include alternate
mRNA splicing (reviewed in Alderton et al., 2001). Finally, a further level of com-
plexity is added by the observation that NOS forms a Fe2þ-heme intermediate, and,
therefore, has the potential to experience a feedback inhibition by NO via formation
of a stable ferrous nitrosyl (Fe2þ–NO) complex (reviewed in Alderton et al., 2001).
A second level of regulation is provided by the intracellular localization of nNOS
and the spatial confinement of the components of the molecular machinery involved
in the mechanisms of stimulation, synthesis and action (Fig. 1). The bivalent PDZ
domain of nNOS targets the enzyme to membranes in synapses and interacts with a
PDZ domain in neuron-specific PSD-95. Since PSD-95 also binds to glutamatePSD
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Fig. 1. Functional coupling of glutamate NMDA receptor with nitric oxide synthase and nitric oxide
signalling pathways. The interaction of NMDA receptor with NOS via PSD-95 facilitates NO synthesis
following Ca2þ influx. Adaptor protein CAPON regulates the supramolecular complex of NO synthesis,
linking nNOS to specific targets (e.g., small G proteins such as Dexras). Intra- and intercellular signalling
pathways are mediated by interaction with soluble guanylate cyclase and thiol groups in proteins. The
NMDA receptor is down-regulated by S-nitrosation of a critical cysteine residue.
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tionally couples NMDA receptor activation to nNOS activity (Christopherson et al.,
1999). In addition to functional evidence coupling NMDA activity with NO syn-
thesis, co-localization of nNOS with NMDA receptors and PSD-95 in hippocampal
dendritic spines using microscopic immunocytochemical methods optimized to de-
tect synaptic antigens, adds strong support to the supramolecular organization of the
signalling pathway across a synapse as a theme for the regulation of NO activity in
the brain (Burette et al., 2002). A first consequence of such organization is that
nNOS must be located within the localized sphere of increased Ca2þ concentration
that occurs following activation of NMDA glutamate receptor, thus facilitating
robust and rapid activation of the enzyme. Moreover, the physical coupling of
NMDA receptor and nNOS by PSD95 can be regulated by the brain-specific adaptor
protein CAPON that competes for the PDZ domain and detaches nNOS from the
NMDA receptor (Jaffrey et al., 1998). Other proteins associated with CAPON (e.g.,
Dexras 1, synapsin) provide structural integrity to the multiprotein complex and
might also be targets for NO (Jaffrey et al., 2002). In this way, adapter proteins such
as CAPON may deliver NO to selective targets.
These are the general lines of thought for discussing the NO signalling and the
extracellular NO measurement in hippocampus that are addressed in the following
sections.2. Nitric oxide targets in physiologic and pathophysiologic pathways
All isoforms of NOS can be expressed in the brain; eNOS in endothelial cells
and neurons, nNOS in neurons (presumably in only 1–2% of the total neuronal
population in many brain regions) and iNOS in activated microglia and
astrocytes (Dawson and Dawson, 1998; Alderton et al., 2001). A neural role of
NO was firstly suggested by observations relating the activation of glutamate
NMDA receptor and NO synthesis in brain slices (reviewed in Garthwaite and
Boulton, 1995). The glutamate NMDA receptor triggers intracellular signalling
pathways that govern neuronal plasticity, development, senescence, and dis-
ease, suggesting a role for NO in these processes (Dawson and Dawson,
1998).
In signalling, the best characterized target for NO is soluble guanylate cyclase
(sGC) which is activated by NO producing cGMP (Ignarro, 1991); sGC is highly
sensitive to NO as half-maximal activation upon NO binding to the heme group
occurs at 2–20 nM (Bellamy et al., 2000). However, recent findings point to the
involvement of NO in signalling pathways independent of cGMP production (Bo-
ehning and Snyder, 2003) (Fig. 1). Noteworthy, those pathways mediated by NO
redox chemistry with thiol groups in proteins and glutathione, likely involving
transition-metal catalysis and interconversion among different redox forms of NO
(e.g. NOþ, the one-electron oxidation derivative). The formation of S-nitrosothiol
proteins, occurring at a single critical cysteine residue has been described in many
proteins and may regulate the function of transcription factors (pointing to a
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(including protein kinases, phosphatases and caspases), structural proteins, etc.
(Stamler et al., 2001). The selectivity of S-nitrosation of peptides and proteins is
suggested by the observation that only a single cysteine residue within an acid–base
or hydrophobic structural motif is modified in vivo. Although the vast majority of
‘‘S-nitrosylated’’ proteins have been described in vitro under conditions of exoge-
nously added NO donors, recent proteomic approaches have identified a population
of endogenously S-nitrosylated proteins, most notably the glutamate NMDA
receptor (Jaffrey et al., 2001; Matsumoto et al., 2003). In a way reminiscent of the
kinase/phosphatase pathways, the dynamic regulation of proteins by nitrosation
requires denitrosation but mechanisms are still uncertain.
Conversely to NMDA-dependent physiologic pathways, excessive activation of
glutamate NMDA receptor, the process termed ‘‘excitotoxicity’’, represents a general
mechanism underlying neurological disorders, ranging from Alzheimer’s disease,
Parkinson’s disease, multiple sclerosis to AIDS dementia (Coyle and Puttfarcken,
1993; Dawson and Dawson, 1998). Although conflicting results exist, it has been
established that NO mediates the toxicity of glutamate in primary cortical cultures
and in a variety of other model systems (Dawson et al., 1991; Dawson and Dawson,
1998).
The current paradigm for NO neurotoxicity states that its concentration is critical
in determining whether it acts as a signalling molecule or as a toxin; in the later case
the effects are mediated by NO-derived reactive species, imposing a ‘‘nitrosative
stress’’. However, a change in concentration does not necessarily imply a qualitative
modification of targets. For instance, NO produced at very high concentrations, in
the lM range, by an inducible NOS in macrophages plays an important role in the
host response to infection, but NO exerts antimicrobial action by modifying selec-
tive thiol and metal centers of critical proteins in pathogens (Stamler et al., 2001).
Thus, at high NO concentrations (lM) in the brain, sGC activation and functional
S-nitrosothiol formation are likely to occur. However, because repair systems might
be overcame, cells and tissues have an additional difficulty to cope with a high
number of dysfunctional events triggered by NO and related species, such as oxi-
dation, nitrosation, and nitration of proteins and DNA. A number of works suggest
that many of the neurotoxic actions of NO are mediated by derived nitrogen species,
including NO2 radical (Ischiropoulos, 1998) and peroxynitrite (ONOO
), the reac-
tion product of the termination reaction of NO and O2 (Radi et al., 1991). For
instance, ONOO was implicated in the apoptosis of hippocampal neurons of
Mongolian gerbils subjected to cerebral ischemia (Cuzzocrea et al., 2000). On the
other hand, superoxide dismutase, which scavenges O2 , thus preventing ONOO

formation, attenuates glutamate, NMDA and NO neurotoxicity (Dawson and
Dawson, 1998). Curiously, NOS-containing neurons are enriched in manganese
superoxide dismutase and are particularly resistant to NMDA and NO toxicity
(Dawson and Dawson, 1998).
Moreover, nitrosative chemistry can trigger secondary oxidative modifications, as
exemplified by oxidation of a cysteine residue in glutathione reductase mediated by
S-nitrosoglutathione (Becker et al., 1998). Also, singlet oxygen, a highly reactive
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with H2O2 (Noronha-Dutra et al., 1993).
At the subcellular level it is important to consider the effects of NO on mito-
chondria (Boveris and Cadenas, 2000; Cadenas et al., 2000) leading to organelle
dysfunction and the involvement of damaged mitochondria in the neurodegenerative
diseases. In rat cortical neurons, NO production and glutamate NMDA receptor
activation is closely linked to intramitochondrial ONOO formation (Solenski et al.,
2003). In neurodegenerative pathologies, NO from the iNOS of activated astrocytes
or microglia might contribute to NO production and inhibit persistently mito-
chondrial respiration in neurons (reviewed in Brown and Bal-Price, 2003). In this
regard, the NO-dependent mitochondrial dysfunction leading to an energy deficient
state may constitute a pathway driving neurodegeneration (Bolanos et al., 1997).
Paradoxically, NO and oxygen free radicals are produced in brain cells during
normal activity and interact in signal transduction pathways (Bindokas et al., 1996).
For instance, neuronal calcium signalling in rat cortical brain slices depends critically
on NO and involves cellular oxygen free radicals utilization (Yermolaieva et al.,
2000) and neuron-glia signalling in CA1 region of hippocampus requires O2 and
NO (Atkins and Sweatt, 1999).
Therefore, a complex picture emerges where oxygen free radicals and NO signals
overlap, cooperate or produce antagonistic effects. Changes in the flux rates and
compartmentalisation of NO and oxygen free radicals may distort signalling cascades
triggering pathologic cellular mechanisms. A remarkable demonstration of this con-
cept was provided a decade ago by Lipton et al. (1993). Using NMDA receptor as a
model the authors pointed out that the redox versality of NO permits its conversion
from a neuroprotective molecule to a neurotoxin; neurotoxicity is mediated by
ONOO but neuroprotection is achieved by down-regulation of NMDA receptor
activity by S-nitrosation (addition of NOþ) of the receptor redox modulatory site.
Since then, other observations including the potentiation of NO synthesis by ascor-
bate (Heller et al., 1999) and the down-regulation ofNMDAreceptor by nitroxyl anion
(NO; Kim et al., 1999), the one-electron reduced form ofNO, stress the notion that a
change in the neuronal redoxmilieu,modulated in part by the balance between reactive
species (such as superoxide anion and H2O2) and neuroprotective compounds (most
notably, ascorbate and glutathione) may determine the biological activity of NO.
Catecholamines may also be active components in modulating the redox envi-
ronment because NO oxidizes dopamine (Daveu et al., 1997, Rettori et al., 2002)
and DOPAC, yielding o-semiquinone radical species and nitroxyl anion in a process
catalysed by superoxide dismutase (Laranjinha and Cadenas, 2002). In view of the
nitroxyl-dependent decrease of NMDA receptor-evoked responses (Kim et al., 1999)
these chemical interactions may acquire biological significance.3. Measurement of NO in hippocampal subregions using electrochemical microsensors
Development of sensitive and selective analytical techniques for the measurement
of NO in biological systems has been a matter of great concern (reviewed in Cadenas
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research explore the physical and chemical properties that support NO biological
activity and provide complementary information. One may tentatively group the
design of methodologies in the following categories:
(1) Ex situ and indirect methods: examples include formation of stable adducts
(e.g., EPR, and UV/VIS detection of hemoglobin–Fe2þ–NO and other NO–iron
complexes), analysis of reaction products (e.g., hemoglobin–Fe3þ, L-citrulline, ni-
trites and nitrates), chemiluminescence (gas phase reaction with ozone and reaction
with luminol/hydrogen peroxide in the liquid phase) and reporter cell assays (Barker
et al., 1999). These approaches require sample processing and, therefore, temporal
resolution is lost.
(2) Incorporation of NO-sensitive indicators in cells: fluorescent compounds have
been developed that in connection with microscopy support imaging approaches to
determine the spatial distribution of NO at cellular and sub-cellular levels. This
interesting approach requires caution due to the influence of medium composition in
the reaction of fluorophores and NO with in the fluorescence properties of fluoro-
phores (Kojima et al., 2001). Compartmentalisation of the fluorophore, pH, inner
filter effects and photodecomposition are issues to be controlled.
(3) Analysis at the tip of a probe inserted into the environment of NO production:
this seems a promising approach as the development of probes with small dimen-
sions affords minimal disturbance of the physiological environment upon its inser-
tion into tissues. Two technologies have been applied in the design of probes:
electrochemistry and chemiluminescence, the later exhibiting much higher limits of
detection.
Whereas each methodology has advantages for particular applications, most
of these approaches provide data that is difficult to translate into the environment of
NO diffusional field in tissues (e.g., microdialysis, EPR) or rely on measurements of
secondary products (e.g., nitrites and nitrates). Considering the role of NO as a
diffusible messenger in the brain, the need to achieve a dynamic detection of NO at
low nM levels in tissues with appropriate spatial and temporal resolution led to the
development of selective electrochemical microsensors in connection with diverse
electrochemical techniques (reviewed in Bedioui and Villeneuve, 2003). Commonly,
electrochemical sensors exhibit a detection limit in the vicinity of 1–10 nM, a linear
response up to lM range and an accuracy of 5–10%.
The electrochemical measurement of NO with sensors in complex biological
media implies modification of the electrode surface with organized coatings (with-
out compromising response time) that improve sensitivity and selectivity. Shibuki
firstly introduced a miniature electrochemical probe consisting in a Pt electrode
covered with a gas-permeable membrane to successfully monitor endogenous NO
production (8–58 nM) in rat cerebellar slices (Shibuki, 1990). Later, Shibuki’s probe
enabled WPI (Sarasota, USA) to develop the first widely commercially available
nitric oxide sensor, the ISO-NO. A second hallmark in the development of micro-
sensors was the introduction of catalytic electrode surfaces by Malinski and
Taha (1992), who used a carbon fiber electrode modified by the electropolymeriza-
tion of Ni(II)-porphyrin. Following this advance, the deposition of polymeric films
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and several materials have been proposed, including different types of metallo-
porphyrins, metallophtalocyanines, copper-platinum microparticles, palladium
and iridium oxide (Bedioui and Villeneuve, 2003). In most cases, the catalytic films
are combined with molecular/ionic filters in order to achieve higher selectivity,
including, as the most common, Nafion, o-phenylenediamine (Friedemann et al.,
1996; Pontie et al., 1999), polylysine and polypyridinium (Mitchell and Michaelis,
1998).
Clearly, it is not only important to consider the design of the sensor to achieve
optimal analytical performance in terms of sensitivity, selectivity and temporal res-
olution. Issues such as experimental conditions for multilayer coatings, construction
procedures, electrical and temporal resolution of the complete detection system,
calibration procedures, stability, electrochemical technique, etc, strongly influence
analytical outcomes. Additionally, temperature and hydrodynamics cause changes in
the amplitude of electrochemical signals that cannot be distinguished from variations
in NO concentration (Allen et al., 2002).
Amperometry is a highly sensitive analytical electrochemical technique (although
suffering from lack of selectivity) often selected to detect NO in vivo, but, under
conditions of high NO concentrations, selectivity can be improved by using fast
cyclic voltammetry (FCV) (Ledo et al., 2002) and differential pulse voltamme-
try (Bedioui and Villeneuve, 2003). The oxidation and reduction peaks obtained
with FCV provide the ‘‘redox signature’’ of the active species. In this way, catec-
hols (dopamine, noradrenaline, DOPAC), indols (serotonine), nitrite and ascor-
bate can be clearly separated from NO signals (Ledo et al., 2002). For instance,
Iravani et al., using a bare carbon electrode reported the simultaneous selective
measurement of NO and dopamine in rat caudate putamen slices (Iravani et al.,
1998).
Fig. 2 shows typical records of NO profiles in the subregions of rat hippocampal
slices, following stimulation of glutamate NMDA receptor with NMDA. The NO
microsensors consisted in glass encased carbon fiber microelectrodes modified with
Nafion and o-phenylenediamine, or Nafion and Ni(II)-porphyrin. The reduced
dimensions of the sensor (100–150 lm in length and 8 lm in diameter) allowed high
spatial resolution, while the amperometric approach conferred temporal resolution
of recordings. The slices were challenged by an injection of NMDA at 50 lm away
from the microsensor insertion point. Recordings were performed in the pyramidal
cell layer of subregions CA1 and CA3, the polymorphic cells of the hilus and the
granular cell layer of the dentate gyrus, DG. The typical kinetic traces shown in Fig.
2 are sensitive to NOS inhibitors and were obtained independently of sensor type, in
an indication that the signal is not an analytical artifact. Considering the high degree
of structural integrity and functionality of the neuronal circuitry retained by the
hippocampal slices, the signals shown represent an increase of NO concentration
from a low nM up to 200 nM, upon stimulation of NMDA receptor. In agreement
with this assumption, Bon and Garthwaite showed that a tonic endogenous NO low
level is required for exogenously added NO to facilitate long-term potentiation in
hippocampal CA1 area (Bon and Garthwaite, 2003). Moreover, the ambient NO
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Fig. 2. Typical recording in subregions of hippocampal slices. The microsensor was inserted 100–200 lm
into the tissue at pl of CA1 and CA3, pm of the hilus and gl of the DG. Tissue stimulation (arrows)
was accomplished by an injection of NMDA (5 mM for 3 s) 50 lm away from the microsensor inser-
tion point, at the surface of the tissue. Inset: Schematic representation of the rat hippocampal
slice, showing the divisions in subregions (CA1 and CA3 in the hippocampal proper and the den-
tate gyrus), the principal cell layers (pl-pyramidal cell layer, gl-granular cell layer, pm-polymorphic cell
layer or hilus) as well as the trisynaptic loop which represents the flow of information in this brain
structure.
84 A. Ledo et al. / Molecular Aspects of Medicine 25 (2004) 75–89concentration in rat striatal slices was estimated as 2–10 nM on basis of guanylate
cyclase activity (Griffiths et al., 2002).
A. Ledo et al. / Molecular Aspects of Medicine 25 (2004) 75–89 85Production of NO is more pronounced in hippocampus CA1 subregion. Con-
sidering only the response to a first stimulation, in CA3, DG and hilus signals are,
respectively, 91%, 95% and 93% smaller as compared with those in CA1 area. The
differences in NO concentration dynamics in the subregions of the hippocampus
elicited through NMDA receptor are in agreement with the observation that
NMDA-dependent LTP is observed mainly in the CA1 area of hippocampus (O’Dell
et al., 1991; Schuman and Madison, 1991). The NO levels in different subregions of
hippocampus challenged with nicotine showed less dramatic differences; CA3 and
DG peak amplitudes were 70% of peak amplitude in CA1 area (Smith et al., 1998).
An imaging approach with diaminofluorescein derivatives also indicated that NO is
produced mainly in CA1 area in hippocampal slices under ischemic conditions
(Kojima et al., 2001).
The dependency of NO dynamics on the hippocampal subregions is not clear but
is possibly related to different levels of expression of NOS. Immunohistochemical
experiments (Burette et al., 2002; Wendland et al., 1994) and Western blots per-
formed in total extracts of the different regions point in this direction (Liu et al.,
2003). On the other hand, a gradient of expression has also been shown for NMDA
receptors, with higher levels being detected in the CA1 subregion (Ozawa et al.,
1998). However, these observations do not rule out other explanations, including a
functional regulation of NO profiles by the redox environment. In addition to
pressure injection, a stimulation by perfusion was also performed. Regardless of the
type of stimulus the concentration dynamics of NO are qualitatively similar
(unpublished results). The transient nature of NO signals indicate that in spite of the
fact that under the stimulation conditions applied multiple NO sources are simul-
taneously being activated, steady-state concentrations are not achieved. As pointed
out before (Lancaster, 1997), and in contrast with the NO mediated relaxation of the
vasculature or under inflammatory conditions where NO concentration is most
likely maintained constant (depending on the availability of substrates and cofac-
tors), the activity of NO as a messenger in the brain is exerted through transient and
fluctuating concentrations.4. Concluding remarks
The hippocampus is part of the medial temporal lobe and has been implicated in
learning and memory formation. Impairment in this brain region is observed during
normal ageing, and a more severe degeneration has been observed in neurodegen-
erative processes with severe memory impairment, as in Alzheimer’s disease. The
diffusional spread of NO in hippocampus has not been quantified yet nor the
relationship between NO concentration and cellular physiology. Certainly, further
progress in understanding the role of NO in the physiology and pathology of this
brain region will be facilitated by the dynamic measurement of NO concentrations
under different stimulation conditions. The concentration-time profiles obtained
with electrochemical microsensors is a first and promising approach to achieve such
goal.
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